Effect of Head Acupuncture on Residual Symptoms After Canalith Repositioning Procedure for Benign Paroxysmal Positional Vertigo: a Single-center Randomized Controlled Trial.

Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and currently, manual repositioning techniques are often used for treatment. However, up to 30%-50% of patients may experience residual symptoms such as non-rotational dizziness, heaviness, instability, and emotional disturbances even after successful repositioning, which significantly impacts their daily functioning and quality of life. Electroacupuncture therapy has been proven to be an effective treatment for dizziness and has been applied to various vestibular disorder patients. However, the efficacy of electroacupuncture on the residual effects of successfully repositioned BPPV patients remains unclear. This study aims to explore the effectiveness of three regimens: electroacupuncture, betahistine in patients with residual symptoms after successful manual repositioning.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful.

• After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted.

• There were no obvious communication barriers or visual impairments.

• The patient and their family members agreed to the treatment plan.

Locations
Other Locations
China
Xi'an No3 Hospital
RECRUITING
Xi'an
Contact Information
Primary
Mingze Chang, PhD
changmingze191@163.com
029+8661816100
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2026-11-01
Participants
Target number of participants: 120
Treatments
Experimental: Group A (acupuncture group)
Treatment patients with residual symptoms after successful manual repositioning by electroacupuncture
Active_comparator: Group B (betahistine group)
Treatment patients with residual symptoms after successful manual repositioning by oral betahistine
Sponsors
Leads: Xi'an No.3 Hospital

This content was sourced from clinicaltrials.gov